QuantumScape achieves a milestone with its “Cobra” separator production process for mass production of its solid-state EV battery.
The UK is seen as a global leader in regulating reproductive technologies. Some worry that onerous paperwork is causing embryos to be wasted.
Everyone wants to meet (and snuggle!) the new baby. How can parents let loved ones know precautions need to be taken so Baby doesn’t get sick?
A thrifty study uncovers a wealth of data about one of the world’s largest and most elusive species.
Batteries made from waste and methane offer lower CO2 emissions than current technologies.
It’s also being claimed that the technology has the potential to improve fast-charging speed by up to 50%, making EV ownership even more convenient. Lithium-sulfur batteries are expected to cost less than half the price per kWh of current lithium-ion batteries, according to Stellantis.
The batteries will be produced using waste materials and methane, with significantly lower CO2 emissions than any existing battery technology. Zeta Energy battery technology is intended to be manufacturable within existing gigafactory technology and would leverage a short, entirely domestic supply chain in Europe or North America, according to a press release.
Ned Curic, Stellantis’s Chief Engineering and Technology Officer, stated that the collaboration with Zeta Energy is another step in helping advance the company’s electrification strategy as they work to deliver clean, safe, and affordable vehicles.
Understanding neonatal brain injury — can it teach us about adult-onset neurodegenerative disease?
Envisioning armies of electronically controllable insects is probably nightmare fuel for most people. But scientists think they could help rescue workers scour challenging and hazardous terrain. An automated cyborg cockroach factory could help bring the idea to life.
The merger of living creatures with machines is a staple of science fiction, but it’s also a serious line of research for academics. Several groups have implanted electronics into moths, beetles, and cockroaches that allow simple control of the insects.
However, building these cyborgs is tricky as it takes considerable dexterity and patience to surgically implant electrodes in their delicate bodies. This means that creating enough for most practical applications is simply too time-consuming.
Its a problem, but im sure ASI by 2035 will solve for a way to use a Crispr type tool with zero unintended alterations. Look for a way to use w/ out alterations in meantime, but worst case ASI will solve it.
Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the world are now working to put these tools to clinical use and are continuously advancing them.
CRISPR-Cas tools allow researchers to modify individual building blocks of genetic material in a precise and targeted manner. Gene therapies based on such gene editing are already being used to treat inherited diseases, fight cancer and create drought-and heat-tolerant crops.
The CRISPR-Cas9 molecular complex, also known as genetic scissors, is the most widely used tool by scientists around the world. It cuts the double-stranded DNA at the exact site where the genetic material needs to be modified. This contrasts with newer gene-editing methods, which do not cut the double strand.